NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation

Abstract DNA methylation regulators play critical roles in modulating oncogenic driver genes in cancers. However, the precise mechanisms through which these DNA methylation regulators influence oncogenesis and clinical therapy have yet to be fully elucidated. This study reveals that hypermethylation...

Full description

Saved in:
Bibliographic Details
Main Authors: Xukun Li, Dandan Fan, Yong Li, Jian Yuan, Wanyuan Sun, Qinghao Zhu, Ling Qi, Xueling Wu, Jiahui Cai, Tongyang Gong, Ning Zhao, Jianzhong Su, Zhihua Liu, Hongyan Chen
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202413508
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235402207625216
author Xukun Li
Dandan Fan
Yong Li
Jian Yuan
Wanyuan Sun
Qinghao Zhu
Ling Qi
Xueling Wu
Jiahui Cai
Tongyang Gong
Ning Zhao
Jianzhong Su
Zhihua Liu
Hongyan Chen
author_facet Xukun Li
Dandan Fan
Yong Li
Jian Yuan
Wanyuan Sun
Qinghao Zhu
Ling Qi
Xueling Wu
Jiahui Cai
Tongyang Gong
Ning Zhao
Jianzhong Su
Zhihua Liu
Hongyan Chen
author_sort Xukun Li
collection DOAJ
description Abstract DNA methylation regulators play critical roles in modulating oncogenic driver genes in cancers. However, the precise mechanisms through which these DNA methylation regulators influence oncogenesis and clinical therapy have yet to be fully elucidated. This study reveals that hypermethylation of under‐methylated regions (UMRs) within gene bodies is involved in the activation of oncogenic homeobox genes, particularly NKX2‐5 and LHX1, in esophageal squamous cell carcinoma (ESCC). Mechanistically, NKX2‐5 and LHX1 synergistically bind to the promoter region of UHRF1, thereby augmenting its transcription. In turn, UHRF1 orchestrates the recruitment of DNMT1/DNMT3A, alongside NKX2‐5 and LHX1, to the UMRs of these genes, thereby increasing DNA methylation levels and their expression. This intricate interplay forms a positive transcriptional feedback loop between NKX2‐5/LHX1 and UHRF1, thus promoting the overexpression of all three genes and ultimately facilitating tumor growth. Notably, concurrent inhibition of UHRF1 and DNMTs impedes tumor growth by suppressing NKX2‐5 and LHX1 expression. Overall, this study identifies a positive feedback regulatory circuitry underlying the UMR hypermethylation‐mediated activation of oncogenic drivers in ESCC and proposes a promising therapeutic strategy for ESCC patients.
format Article
id doaj-art-2ab1c7fee11b4fd988d8354640c670d2
institution OA Journals
issn 2198-3844
language English
publishDate 2025-05-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-2ab1c7fee11b4fd988d8354640c670d22025-08-20T02:02:16ZengWileyAdvanced Science2198-38442025-05-011220n/an/a10.1002/advs.202413508NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic DysregulationXukun Li0Dandan Fan1Yong Li2Jian Yuan3Wanyuan Sun4Qinghao Zhu5Ling Qi6Xueling Wu7Jiahui Cai8Tongyang Gong9Ning Zhao10Jianzhong Su11Zhihua Liu12Hongyan Chen13The State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital Wenzhou Medical University Wenzhou Zhejiang 325101 P. R. ChinaDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital Wenzhou Medical University Wenzhou Zhejiang 325101 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital Wenzhou Medical University Wenzhou Zhejiang 325101 P. R. ChinaDepartment of Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital Wenzhou Medical University Wenzhou Zhejiang 325101 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaThe State Key Laboratory of Molecular Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. ChinaAbstract DNA methylation regulators play critical roles in modulating oncogenic driver genes in cancers. However, the precise mechanisms through which these DNA methylation regulators influence oncogenesis and clinical therapy have yet to be fully elucidated. This study reveals that hypermethylation of under‐methylated regions (UMRs) within gene bodies is involved in the activation of oncogenic homeobox genes, particularly NKX2‐5 and LHX1, in esophageal squamous cell carcinoma (ESCC). Mechanistically, NKX2‐5 and LHX1 synergistically bind to the promoter region of UHRF1, thereby augmenting its transcription. In turn, UHRF1 orchestrates the recruitment of DNMT1/DNMT3A, alongside NKX2‐5 and LHX1, to the UMRs of these genes, thereby increasing DNA methylation levels and their expression. This intricate interplay forms a positive transcriptional feedback loop between NKX2‐5/LHX1 and UHRF1, thus promoting the overexpression of all three genes and ultimately facilitating tumor growth. Notably, concurrent inhibition of UHRF1 and DNMTs impedes tumor growth by suppressing NKX2‐5 and LHX1 expression. Overall, this study identifies a positive feedback regulatory circuitry underlying the UMR hypermethylation‐mediated activation of oncogenic drivers in ESCC and proposes a promising therapeutic strategy for ESCC patients.https://doi.org/10.1002/advs.202413508DNA methylationLHX1NKX2‐5transcriptional dysregulationUHRF1
spellingShingle Xukun Li
Dandan Fan
Yong Li
Jian Yuan
Wanyuan Sun
Qinghao Zhu
Ling Qi
Xueling Wu
Jiahui Cai
Tongyang Gong
Ning Zhao
Jianzhong Su
Zhihua Liu
Hongyan Chen
NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
Advanced Science
DNA methylation
LHX1
NKX2‐5
transcriptional dysregulation
UHRF1
title NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
title_full NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
title_fullStr NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
title_full_unstemmed NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
title_short NKX2‐5/LHX1 and UHRF1 Establishing a Positive Feedback Regulatory Circuitry Drives Esophageal Squamous Cell Carcinoma through Epigenetic Dysregulation
title_sort nkx2 5 lhx1 and uhrf1 establishing a positive feedback regulatory circuitry drives esophageal squamous cell carcinoma through epigenetic dysregulation
topic DNA methylation
LHX1
NKX2‐5
transcriptional dysregulation
UHRF1
url https://doi.org/10.1002/advs.202413508
work_keys_str_mv AT xukunli nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT dandanfan nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT yongli nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT jianyuan nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT wanyuansun nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT qinghaozhu nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT lingqi nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT xuelingwu nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT jiahuicai nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT tongyanggong nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT ningzhao nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT jianzhongsu nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT zhihualiu nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation
AT hongyanchen nkx25lhx1anduhrf1establishingapositivefeedbackregulatorycircuitrydrivesesophagealsquamouscellcarcinomathroughepigeneticdysregulation